---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-010148"
form_type: "8-K"
ticker: "ACHV"
cik: "0000949858"
company_name: "ACHIEVE LIFE SCIENCES, INC."
filed_at: "2022-03-15T23:59:59+00:00"
generated_at: "2026-06-26T23:02:01.332274+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Achieve Life Sciences appoints Vaughn Himes, PhD to Board of Directors

## Summary
- Dr. Himes appointed as director effective March 14, 2022; no committee assignment yet.
- Annual cash retainer of $40,000 for Board service.
- Initial option grant for 6,600 shares, vesting monthly over 36 months, exercise price at Nasdaq close on grant date.
- No arrangements, family relationships, or material interests per Item 404(a) reported.

## SEC filing metadata
- accession: 0001564590-22-010148
- form_type: 8-K
- ticker: ACHV
- cik: 0000949858
- company_name: ACHIEVE LIFE SCIENCES, INC.
- filed_at: 2022-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/949858/000156459022010148/0001564590-22-010148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/949858/000156459022010148/achv-8k_20220308.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-010148
- JSON: https://secwatch.observer/filing/0001564590-22-010148.json
- Plain text: https://secwatch.observer/filing/0001564590-22-010148.txt

## Key facts
- Executive change
  Vaughn Himes was appointed as director at ACHIEVE LIFE SCIENCES, INC..
  - Action: appointed
  - Role: director
  source text: the Board of Directors (the “ Board ”) of Achieve Life Sciences, Inc. (the “ Company ”) appointed Vaughn Himes, PhD., as a director, effective March 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/949858/000156459022010148/0001564590-22-010148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.